Drawing for FLEN PHARMA

USPTO serial 79167184

FLEN PHARMA

Reviewed by CopyMark Law Group

Reg. 4911439Status 404
Filing date
Status date
Registration date
Mar 8, 2016
Examiner
GILLES, DEBORAH LYNN MEINERS
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with FLEN PHARMA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Clifford D. Hyra

Clifford D. Hyra Fresh IP PLC11710 Plaza America Drive Suite 2000Reston, VA 20190UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Commercial trading and consumer information services in the field of wound-treatment and pharmaceutical research and development of products for wound-treatment, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; demonstration of goods for advertising and promotional purposes; wholesale store and retail store services of pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; consultancy and providing information regarding the aforesaid services, via the internet or otherwise, online or via other electronic channelsSECTION 71 - CANCELLED—
042Consultation services in the field of biotechnology, pharmaceutical research and development; scientific analysis services in the field of biotechnology, pharmaceutical research and development, diagnostics, and drug therapy for the purpose of developing wound-treatment products, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; biological and pharmaceutical research and development services for others; clinical research in the field of wound-treatment and pharmaceutical research and development of products for wound-treatment, pharmaceutical preparations, dietetic substances adapted for medical use and cosmetics; pharmaceutical product evaluation; research on the subject of pharmaceuticals; pharmaceutical research and development services; pharmaceutical drug development services; laboratory research in the field of analytical and medicinal chemistry, biology, pharmacology and toxicology; clinical development services, namely, services related to pharmaceutical research and development of products for wound-treatment, pharmaceutical preparations, dietetic substances adapted for medical use and cosmeticsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 12, 2025DENANOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED—
Sep 12, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 21, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 24, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 24, 2023INPCINVALIDATION PROCESSED—
May 23, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 23, 2022C71TCANCELLED SECTION 71—
Mar 8, 2021REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 17, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 7, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Aug 31, 2017ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 23, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 20, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jun 20, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Jun 8, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 8, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 4, 2016GPNXNOTIFICATION PROCESSED BY IB—
Dec 22, 2015NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 22, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 16, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 2, 2015NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 13, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 13, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Oct 13, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 13, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 13, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 29, 2015XAECEXAMINER'S AMENDMENT ENTERED—
Sep 29, 2015GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 29, 2015GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 29, 2015CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 24, 2015ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2015REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Aug 27, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 18, 2015RFNTREFUSAL PROCESSED BY IB—
Jun 30, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jun 30, 2015RFRRREFUSAL PROCESSED BY MPU—
Jun 30, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jun 30, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Jun 29, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 24, 2015DOCKASSIGNED TO EXAMINER—
Jun 24, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jun 18, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance